It does not appear toxic, does not accumulate in tissues, and has been well tolerated in trials
Stacked on top of insulin or a sulfonylurea it can, and the lever is de-intensifying that background drug, not lowering the tirzepatide dose. Over-loss in low-BMI deep responders Across the obesity trials, about 7% of participants fell below a BMI of 22, some by week 12
Medical oversight ensures proper dosing and monitoring
Additionally, if you have a B12 deficiency on top of medical obesity, these two injections can greatly improve your quality of life
One characteristic of this synthetic peptide that scientific literature outlines is its stability
A 2014 study in the Journal of Physiology and Pharmacology documenting BPC-157 and accelerated tendon healing with improved collagen fiber architecture